1. Home
  2. Topics
  3. Amgen Inc.
Amgen Inc.

Amgen Inc.

Editor's Picks

There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.

Related Articles

  1. BIG BEAR LAKE, Calif. (AP) – Sylvain Georges of France pedaled to a long, solo win and Dave Zabriskie of Salt Lake City maintained his race lead Friday in the mountainous stage 6 of the Amgen Tour of California. France's Sylvain Georges of team AG2R La M Full Article at USA Today

  2. Defending champion Chris Horner rides in the peloton during stage one of the Amgen Tour of California on Sunday in Santa Rosa. Defending champion Chris Horner rides in the peloton during stage one of the Amgen Tour of California on Sunday in Santa Rosa. Full Article at USA Today

  3. AtLeast one of the check box should be selected You are following news about Follow the latest news about AMGN THOUSAND OAKS, Calif. , May 16, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced updated results from a Phase 2 study that showed treat Full Article at PR Newswire

  4. AtLeast one of the check box should be selected You are following news about Follow the latest news about AMGN THOUSAND OAKS, Calif. , May 16, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced today results from an exploratory biomarker analysis evaluat Full Article at PR Newswire

  5. Summary GlobalData, the industry analysis specialist, has released its new report, "Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019". The report is an essential source of information and analysis on the global neur Full Article at PR Newswire

  6. NEW YORK, May 15, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p0861913/Osteoporosis-Drug-Market--Global-And-China-Market-Analysis-Size-Trends-And-Forecast-20 Full Article at PR Newswire

  7. NEW YORK, May 15, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: `The In Vitro Diagnostic (IVD) industry has been confronting a range of issues, such as regulations, industry consolidation Full Article at PR Newswire

  8. APTOS, California (AP) – Peter Sagan of Slovakia won his second straight stage with a powerful and unchallenged sprint to retain the overall lead Monday after stage 2 of the Tour of California. Peter Sagan of Slovakia celebrates as he crosses the finish Full Article at USA Today

  9. Peter Sagan of Solvokia, riding for the Liquigas-Cannondale team, is awarded the best young rider jersey after stage one of the Amgen Tour of California on May 13, 2012 in Santa Rosa, California. Peter Sagan of Solvokia, riding for the Liquigas-Cannondal Full Article at USA Today

  10. AtLeast one of the check box should be selected You are following news about Follow the latest news about AMGN THOUSAND OAKS, Calif. , May 11, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced today that Joseph P. Miletich, M.D. , Ph.D. , senior vice pre... Full Article at PR Newswire

  11. AtLeast one of the check box should be selected You are following news about Follow the latest news about NSC NORFOLK, Va. , May 10, 2012 /PRNewswire/ -- Saying "we can look back with a lot of satisfaction" on 2011's record performance by Norfolk Southern Full Article at PR Newswire

  12. NEW YORK, May 10, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: GBI Research's analysis shows that the overall global Oncology orphan disease market is expected to grow at a significant c Full Article at PR Newswire

  13. Summary GBI Research, the leading business intelligence provider, has released its latest research "Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematos Full Article at PR Newswire

  14. Washington, D.C. and THOUSAND OAKS, Calif. (May 9, 2012) /PRNewswire/ — The Cancer Support Community (CSC) and the Amgen Foundation, today announced the launch of Open to Options™, a program designed to bridge the communications gap between physicians an Full Article at PR Newswire

  15. LOS ANGELES, May 8, 2012 /PRNewswire/ -- Roger and Ann Worthington, longtime supporters of mesothelioma patients and their families, generously donated $25,000 to The Pacific Meso Center (PMC). "Their donation honors the mesothelioma patients and their f Full Article at PR Newswire

  16. SAN FRANCISCO, May 8, 2012 /PRNewswire/ -- Sutro Biopharma today announced the closing of the $16.5 million second tranche of its Series C financing. This financing was led by Skyline Ventures and included participation of Lilly Ventures, Amgen Ventures, Full Article at PR Newswire

  17. Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufactur Full Article at PR Newswire

  18. About Amgen Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab t Full Article at PR Newswire

  19. NEW YORK, May 2, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Where are dermatological treatments heading? Visiongain's report shows you potential revenues to 2022, with data, forecasts Full Article at PR Newswire

  20. THOUSAND OAKS, Calif. , May 1, 2012 /PRNewswire/ -- Amgen today announced that four individuals who have made a difference for others affected by cancer in their communities have been selected as Breakaway from Cancer® Champions. They will be honored at t Full Article at PR Newswire

About This Topic

Wikipedia

There are no results for this module. Edit this module to change the search term used to query Wikipedia

Edit module to insert your ad code